Merit Medical Elects Scott Ward
Analysis based on 6 articles · First reported May 19, 2026 · Last updated May 19, 2026
The election of Scott R. Ward to the Board of Directors of Inspire Medical Systems is viewed positively by the market, as his extensive experience in the medical device industry is expected to contribute to the company's strategic priorities and long-term growth. This could lead to a slight positive sentiment for Inspire Medical Systems stock, especially given its current trading near a 52-week low and an 'undervalued' assessment by InvestingPro.
Inspire Medical Systems, a global manufacturer of healthcare technology, announced that its shareholders elected Scott R. Ward to the company's Board of Directors for a three-year term at their annual meeting. Scott R. Ward brings over 40 years of experience in the healthcare and medical device industry, including senior leadership roles at Medtronic and as CEO, President, and Chairman of Cardiovascular Systems, which was acquired by Abbott Laboratories. He is also the founder of Raymond Holdings. The Board of Directors of Inspire Medical Systems has appointed Scott R. Ward to serve on its Governance and Sustainability and Finance and Operating Committees. This appointment is expected to provide valuable strategic insight and leadership to Inspire Medical Systems as it continues to advance its growth strategy.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard